Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
JAMA Network Open · 04.05.2023 · 6 (5) · e2311673
DOI: 10.1001/jamanetworkopen.2023.11673 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 04.05.2023. Verfasst von Rikki A Cannioto und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance The American Institute for Cancer Research and American Cancer Society regularly publish modifiable lifestyle recommendations for cancer prevention. Whether these recommendations have an impact on high-risk breast cancer survival remains unknown.
Objective
To investigate whether adherence to cancer prevention recommendations before, during, and 1 and 2 years after breast cancer treatment was associated with disease recurrence or mortality. Design, Setting, and Participants The Diet, Exercise, Lifestyles, and Cancer Prognosis Study (DELCaP) was a prospective, observational cohort study designed to assess lifestyles before diagnosis, during treatment, and at 1 and 2 years after treatment completion, implemented ancillary to the Southwest Oncology Group (SWOG) S0221 trial, a multicenter trial that compared chemotherapy regimens in breast cancer. Participants were chemotherapy-naive patients with pathologic stage I to III high-risk breast cancer, defined as node-positive disease with hormone receptor–negative tumors larger than 1 cm or any tumor larger than 2 cm. Patients with poor performance status and comorbidities were excluded from S0221. The study was conducted from January 1, 2005, to December 31, 2010; mean (SD) follow-up time for those not experiencing an event was 7.7 (2.1) years through December 31, 2018. The analyses reported herein were performed from March 2022 to January 2023. Exposure An aggregated lifestyle index score comprising data from 4 time points and 7 lifestyles, including (1) physical activity, (2) body mass index, (3) fruit and vegetable consumption, (4) red and processed meat intake, (5) sugar-sweetened beverage consumption, (6) alcohol consumption, and (7) smoking. Higher scores indicated healthier lifestyle. Main Outcomes and Measures Disease recurrence and all-cause mortality.
Results
A total of 1340 women (mean [SD] age, 51.3 [9.9] years) completed the baseline questionnaire. Most patients were diagnosed with hormone-receptor positive breast cancer (873 [65.3%]) and completed some education beyond high school (954 [71.2%]). In time-dependent multivariable analyses, patients with highest vs lowest lifestyle index scores experienced a 37.0% reduction in disease recurrence (hazard ratio, 0.63; 95% CI, 0.48-0.82) and a 58.0% reduction in mortality (hazard ratio, 0.42; 95% CI, 0.30-0.59). Conclusions and Relevance In this observational study of patients with high-risk breast cancer, strongest collective adherence to cancer prevention lifestyle recommendations was associated with significant reductions in disease recurrence and mortality. Education and implementation strategies to help patients adhere to cancer prevention recommendations throughout the cancer care continuum may be warranted in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- Slone Epidemiology Center, Boston University, Boston, Massachusetts.
- Southwest Oncology Group Statistics and Data Management Center, Fred Hutchinson Cancer Center, University of Washington, Seattle.
- Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.
- Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio.
Förderung
- NCI NIH HHS
Zitieren
APA
Cannioto, R. A., Attwood, K. M., Davis, E. W., Mendicino, L. A., Hutson, A., Zirpoli, G. R., Tang, L., Nair, N. M., Barlow, W., Hershman, D. L., Unger, J. M., Moore, H. C. F., Isaacs, C., Hobday, T. J., Hortobagyi, G. N., Gralow, J. R., Albain, K. S., Budd, G. T., & Ambrosone, C. B. (2023). Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer. JAMA Network Open, 6(5), e2311673. https://doi.org/10.1001/jamanetworkopen.2023.11673
Vancouver
Cannioto RA, Attwood KM, Davis EW, Mendicino LA, Hutson A, Zirpoli GR, et al. Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer. JAMA Network Open. 2023;6(5):e2311673. doi:10.1001/jamanetworkopen.2023.11673
BibTeX
@article{Cannioto2023,
author = {Cannioto, Rikki A and Attwood, Kristopher M and Davis, Evan W and Mendicino, Lucas A and Hutson, Alan and Zirpoli, Gary R and Tang, Li and Nair, Nisha M and Barlow, William and Hershman, Dawn L and Unger, Joseph M and Moore, Halle C F and Isaacs, Claudine and Hobday, Timothy J and Hortobagyi, Gabriel N and Gralow, Julie R and Albain, Kathy S and Budd, G Thomas and Ambrosone, Christine B},
title = {Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {5},
pages = {e2311673},
doi = {10.1001/jamanetworkopen.2023.11673}
}
EUVIMED